Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 10, keine Gesamtzahl für „Simponi“
Suchtreffer
Begriffe & Kennungen
Simponi · 4.8 · Summary of the safety profile In the controlled period of the pivotal trials in RA, PsA, AS, nr-Axial SpA, and
Eintrag öffnenSimponi · 4.8 · Summary of the safety profile In the controlled period of the pivotal trials in RA, PsA, AS, nr-Axial SpA, and
Eintrag öffnenSimponi · 4.8 · Summary of the safety profile In the controlled period of the pivotal trials in RA, PsA, AS, nr-Axial SpA, and
Eintrag öffnenSimponi · 4.8 · Summary of the safety profile In the controlled period of the pivotal trials in RA, PsA, AS, nr-Axial SpA, and
Eintrag öffnenSimponi · 4.8 · Table 1 Tabulated list of ARs Infections and infestations Very common: Upper respiratory tract infection (naso
Eintrag öffnenSimponi · 4.8 · Table 1 Tabulated list of ARs Infections and infestations Very common: Upper respiratory tract infection (naso
Eintrag öffnenSimponi · 4.8 · Table 2 Tabulated list of ARs Infections and infestations Very common: Upper respiratory tract infection (naso
Eintrag öffnenSimponi · 4.8 · Table 2 Tabulated list of ARs Infections and infestations Very common: Upper respiratory tract infection (naso
Eintrag öffnenSimponi · 4.8 · Table 2 Tabulated list of ARs Infections and infestations Very common: Upper respiratory tract infection (naso
Eintrag öffnenSimponi · 4.8 · Tabulated list of adverse reactions ARs observed in clinical studies and reported from world-wide post-marketi
Eintrag öffnenSimponi · 4.8 · Tabulated list of adverse reactions ARs observed in clinical studies and reported from world-wide post-marketi
Eintrag öffnenSimponi · 4.8 · Tabulated list of adverse reactions ARs observed in clinical studies and reported from world-wide post-marketi
Eintrag öffnenSimponi · 4.8 · Tabulated list of adverse reactions ARs observed in clinical studies and reported from world-wide post-marketi
Eintrag öffnenSimponi · 4.8 · Throughout this section, median duration of follow-up (approximately 4 years) is generally presented for all g
Eintrag öffnenSimponi · 4.8 · Throughout this section, median duration of follow-up (approximately 4 years) is generally presented for all g
Eintrag öffnenSimponi · 4.8 · Throughout this section, median duration of follow-up (approximately 4 years) is generally presented for all g
Eintrag öffnenSimponi · 4.8 · Throughout this section, median duration of follow-up (approximately 4 years) is generally presented for all g
Eintrag öffnenSimponi · 4.8 · Throughout this section, median duration of follow-up (approximately 4 years) is generally presented for all g
Eintrag öffnenSimponi · 4.8 · Within the RA, PsA, AS, and nr-Axial SpA pivotal trials, one patient in an RA trial with pre-existing liver ab
Eintrag öffnenSimponi · 4.8 · Within the RA, PsA, AS, and nr-Axial SpA pivotal trials, one patient in an RA trial with pre-existing liver ab
Eintrag öffnen